Xiaoyong Yang, PhD

Dr. Xiaoyong Yang is a professor in the Department of Comparative Medicine and Department of Cellular and Molecular Physiology at Yale University School of Medicine. He received B.S. from Nankai University, M.S. from Peking University, and Ph.D. from University of Alabama at Birmingham. He completed his postdoctoral training with Dr. Ronald Evans at The Salk Institute. Dr. Yang works at the intersection of diabetes, obesity, and cancer. He has made pioneering contributions to deciphering biological information encoded in protein modifications. Dr. Yang has published highly cited articles in scientific journals such as Nature, Cell, and Cell Metabolism, and has been featured in public media outlets such as TIME, Daily Mail, NPR, and Scientific American. He has served on scientific review panels for the NIH, NASA, American Diabetes Association, American Cancer Society, The Medical Research Council, The Wellcome Trust, and others from around the world. Dr. Yang is the founder of the Cancer Metabolism Initiative (CAMI) and a member of the Faculty Advisory Council at Yale School of Medicine. He holds an adjunct professor position at Johns Hopkins University School of Medicine. Dr. Yang has played leadership roles in professional societies as president of CADA and vice president of SAPA. He has been elected to The Connecticut Academy of Science and Engineering.